93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of